𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Statin use and risk of breast cancer

✍ Scribed by Gaia Pocobelli; Polly A. Newcomb; Amy Trentham-Dietz; Linda Titus-Ernstoff; John M. Hampton; Kathleen M. Egan


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
89 KB
Volume
112
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND.

Findings that statins inhibited the proliferation of breast cancer cells in vitro and in rodents have raised interest in whether the use of statins might decrease a woman's risk of developing breast cancer. We analyzed data from a population‐based case‐control study to evaluate the association between the use of statins and breast cancer risk.

METHODS.

Cases of incident invasive breast cancer in women 50 years of age or older and diagnosed from 1995–2001 were identified from population‐based cancer registries in Wisconsin, Massachusetts, and New Hampshire. Controls were randomly selected, within each state, from lists of licensed drivers and Medicare beneficiaries. Information on the use of statins and other breast cancer risk factors was ascertained from structured telephone interviews.

RESULTS.

Overall, breast cancer cases were not more likely than controls to have ever used statins. Ever use of lipophilic statins as a group (simvastatin, lovastatin, and fluvastatin) and ever use of the hydrophilic statin pravastatin were also not associated with breast cancer risk. Ever use of fluvastatin was associated with a decreased risk of breast cancer (odds ratio [OR], 0.5; 95% confidence interval, 0.3–0.8) but the magnitude of the ORs did not vary across categories of duration of use.

CONCLUSIONS.

The use of statins overall was not associated with breast cancer risk. Cancer 2008. Β© 2007 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


Antihistamine use and breast cancer risk
✍ Victoria Nadalin; Michelle Cotterchio; Nancy Kreiger πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 61 KB πŸ‘ 2 views

## Abstract Antihistamines are structurally similar to DPPE, a tamoxifen derivative known to promote tumor growth, and to antidepressants. Animal experiments have linked certain antihistamines and antidepressants with enhanced tumor growth in mice. The few epidemiologic studies examining antihistam

Cimetidine Use and Risk of Breast, Prost
✍ Laurel A Habel; Theodore R Levin; Gary D Friedman πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

Purpose - The study was conducted to examine whether use of cimetidine is associated with the risk of cancer, with special attention to cancers of the breast and prostate because cimetidine increases estradiol levels and interferes with androgen binding. Methods - Individuals who received a prescrip

Statins and risk of cancer: A systematic
✍ Danielle R.L. Browning; Richard M. Martin πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 293 KB πŸ‘ 2 views

## Abstract We conducted a systematic review of the association between HMG‐CoA reductase inhibitor (statin) use and cancer risk. We searched MEDLINE, EMBASE, Web of Science, ISI Proceedings and BIOSIS Previews bibliographic databases, electronic trials registers and reference lists for potentially

Oral contraceptive use and risk of breas
✍ Laura M. Newcomer; Polly A. Newcomb; Amy Trentham-Dietz; Matthew P. Longnecker; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 62 KB πŸ‘ 1 views

We examined the association between oral contraceptive use and risk of specific breast cancer histopathologies in a large, multi-center, population-based, case-control study. Women younger than age 75 with a new diagnosis of invasive breast cancer were identified from 4 statewide tumor registries. W

Coffee and breast cancer risk
✍ Mauricio Z. Baptista; Kadri Altundag; Ozden Altundag πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 32 KB πŸ‘ 2 views